Journal Mobile Options
Table of Contents
Vol. 56, No. 2-3, 2007
Issue release date: February 2008
Neuropsychobiology 2007;56:93–97

Serum BDNF Levels in Suicide Attempters Related to Psychosocial Stressors: A Comparative Study with Depression

Deveci A. · Aydemir O. · Taskin O. · Taneli F. · Esen-Danaci A.
Departments of aPsychiatry and bBiochemistry, Faculty of Medicine, Celal Bayar University, Manisa, Turkey

Individual Users: Register with Karger Login Information

Please create your User ID & Password

Contact Information

I have read the Karger Terms and Conditions and agree.

To view the fulltext, please log in

To view the pdf, please log in


Although many studies have examined the neurobiological aspects of suicide, the molecular mechanisms and pathophysiologic mechanisms associated with suicide remain unclear. In this study, it is aimed to investigate whether there is a difference in serum brain-derived neurotrophic factor (BDNF) levels among suicide attempters without a major psychiatric disorder, compared to major depressive disorder patients and healthy subjects. It was undertaken with the hypothesis that suicide per se lowers serum BDNF levels, since it is a source of stress. The study was carried out in Celal Bayar University Hospital, Manisa, Turkey. Ten suicide attempters, 24 patients with major depressive disorder and 26 subjects without any psychiatric diagnosis and any psychiatric treatment were included in the study. All subjects were asked to give their written consent. Blood samples were collected at the baseline. Serum BDNF was kept at –70°C before testing, and assayed with an ELISA kit (Promega; Madison, Wisc., USA) after dilution with the block and sample solution provided with the kit. The data were subjected to the Kruskal-Wallis test for nonparametric analysis of variance. Mean serum BDNF levels were significantly lower in the suicide group (21.2 ± 12.4 ng/ml) and the major depressive disorder group (21.2 ± 11.3 ng/ml) than the control group (31.4 ± 8.8 ng/ml; p = 0.004). These results suggest that BDNF may play an important role in the neurobiology of suicidal behavior. BDNF levels may be a biological marker for suicidal behavior. To investigate the role of BDNF in suicide, further studies with a wider sample size and a variety of psychiatric diagnoses accompanying suicide attempt are needed.

Copyright / Drug Dosage

Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher or, in the case of photocopying, direct payment of a specified fee to the Copyright Clearance Center.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in goverment regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.


  1. Roy A: Psychiatric emergencies; in Sadock BJ, Sadock VA (eds): Kaplan and Sadock’s Comprehensive Textbook of Psychiatry, ed 7. Baltimore, Williams & Wilkins, 2000, pp 2031–2055.
  2. Gould MS, Wallenstein S, Kleinman M: Time-space clustering of teenage suicide. Am J Epidemiol 1990;131:71–78.
  3. Baxter D, Appleby L: Case register study of suicide risk in mental disorders. Br J Psychiatry 1999;175:322–326.
  4. Sır A: Diyarbakır’da Özkıyım ve Özkıyım Girişimleri. Turk Psikiyatri Derg 1999;10:50–58.
  5. McClure GMG: Changes in suicide in England and Wales, 1960–1997. Br J Psychiatry 2000;176:64–67.
  6. Jones JS, Stanley B, Mann JJ, Frances AJ, Guido JR, Traskman-Bendz L, Winchel R, Brown RP, Stanley M: CSF 5-HIAA and HVA concentrations in elderly depressed patients who attempted suicide. Am J Psychiatry 1990;147:1225–1227.
  7. Nordstrom P, Samuelsson M, Asberg M, Traskman-Bendz L, Aberg-Wistedt A, Nordin C, Bertilsson L: CSF 5-HIAA predicts suicide risk after attempted suicide. Suicide Life Threat Behav 1994;24:1–9.
  8. Kamali M, Oquendo MA, Mann JJ: Understanding the neurobiology of suicidal behavior. Depression Anxiety 2001;14:164–176.
  9. Mann JJ, Brent DA, Arango V: The neurobiology and genetics of suicide and attempted suicide: a focus on the serotonergic system. Neuropsychopharmacology 2001;24:467–477.
  10. Mann JJ: Neurobiology of suicidal behaviour. Nat Rev Neurosci 2003;4:819–828.
  11. Marazziti D, Presta S, Silvestri S, Battistini A, Mosti L, Balestri S, Palego L, Conti L: Platelet markers in suicide attempters. Prog Neuropsychopharmacol Biol Psychiatry 1995;19:375–383.
  12. McAllister AK: Neurotrophins and neuronal differentiation in the central nervous system. Cell Mol Life Sci 2001;58:1054–1060.
  13. Poo MM: Neurotrophins as synaptic modulators. Nat Rev Neurosci 2001;2:24–32.
  14. Spina MB, Hyman C, Squinto S, Lindsay RM: Brain-derived neurotrophic factor protects dopaminergic cells from 6-hydroxydopamine toxicity. Ann NY Acad Sci 1992;648:348–350.
  15. Lewin GR, Barde YA: Physiology of the neurotrophins. Annu Rev Neurosci 1996;19:289–317.
  16. Smith MA, Makino S, Kvetnansky R, Post RM: Stress and glucocorticoids affect the expression of brain-derived neurotrophic factor and neurotrophin-3 mRNAs in the hippocampus. J Neurosci 1995;15:1768–1777.
  17. Scaccianoce S, Lombardo K, Angelucci I: Nerve growth factor brain concentration and stress: changes depend on type of stressor and age. Int Dev Neurosci 2000;18:469–479.
  18. Alfonso J, Pollevick GD, Vander Hart MG, Flugge G, Fucks E, Frasch AC: Identification of genes regulated by chronic psychosocial stress and antidepressant treatment in the hippocampus. Eur J Neurosci 2004;19:659–666.
  19. Lopez JF, Vazquez DM, Chalmers DT, Watson SJ: Regulaton of 5-HT receptors and the hypothalamic-pituitary-adrenal axis. Implications for the neurobiology of suicide. Ann NY Acad Sci 1997;836:106–134.
  20. Duman RS: Synaptic plasticity and mood disorders. Mol Psychiatry 2002;7(suppl 1): 29–34.

    External Resources

  21. Karege F, Perret G, Bondolfi G, Schwald M, Bertschy G, Aubry JM: Decreased serum brain-derived neurotrophic factor levels in depressed patients. Psychiatry Res 2002;109:143–148.
  22. Altar CA: Neurotrophins and depression. Trends Pharmacol Sci 1999;20:59–61.
  23. Chen B, Dowlatshaki D, MacQueen GM, Wang JF, Young LT: Increased hippocampal BDNF immunoreactivity in subjects treated with antidepressant medication. Biol Psychiatry 2001;50:260–265.
  24. Scaccianoce S, Del Bianco P, Caricasole A, Nicoletti F, Catalani A: Relationship between learning, stress and hippocampal brain-derived neurotrophic factor. Neuroscience 2003;121:825–828.
  25. Shimizu E, Hashimoto K, Okamura N, Koike K, Komatsu N, Kumakiri C, Nakazato M, Watanabe H, Shinoda N, Okada S, Iyo M: Alterations of serum levels of brain-derived neurotrophic factor (BDNF) in depressed patients with or without antidepressants. Biol Psychiatry 2003;54:70–75.
  26. Aydemir O, Deveci A, Taneli F: The effect of chronic antidepressant treatment on serum brain-derived neurotrophic factor levels in depressed patients: a preliminary study. Prog Neuropsychopharmacol Biol Psychiatry 2005;29:261–265.
  27. Dwivedi Y, Rizavi HS, Conley RR, Roberts RC, Tamminga CA, Pandey GN: Altered gene expression of brain-derived neurotrophic factor and receptor tyrosine kinase B in postmortem brain of suicide subjects. Arch Gen Psychiatry 2003;60:804–815.
  28. Ozkurkcugil A, Aydemir O, Yildiz M, Esen Danaci A, Koroglu E: Adaptation into Turkish and reliability study of structured clinical interview for DSM-IV axis I disorders. Med Treat J 1999;12:233–236.
  29. Lopez JF, Palkovits M, Arato M, Mansour A, Akil H, Watson SJ: Localization and quantification of pro-opiomelanocortin mRNA and glucocorticoid receptor mRNA in pituitaries of suicide victims. Neuroendocrinology 1992;56:491–501.
  30. Hiroi N, Wong ML, Licinio J, Park C, Young M, Gold PW, Chrousos GP, Bornstein SR: Expression of corticotropin releasing hormone receptors type I and type II mRNA in suicide victims and controls. Mol Psychiatry 2001;6:540–546.
  31. Pfennig A, Kunzel HE, Kern N, Ising M, Majer M, Fuchs B, Ernst G, Holsboer F, Binder EB: Hypothalamus-pituitary-adrenal system regulation and suicidal behavior in depression. Biol Psychiatry 2005;57:336–342.
  32. Brent DA, Mann JJ: Family genetic studies, suicide, and suicidal behavior. Am J Med Genet C Semin Med Genet 2005;133:13–24.
  33. Kim YK, Lee HP, Won SD, Park EY, Lee HY, Lee BH, Lee SW, Yoon D, Han C, Kim DJ, Choi SH: Low plasma BDNF is associated with suicidal behavior in major depression. Prog Neuropsychopharmacol Biol Psychiatry 2007;31:78–85.
  34. Karege F, Vaudan G, Schwald M, Perroud N, La Harpe R: Neurotrophin levels in postmortem brains of suicide victims and the effects of antemortem diagnosis and psychotrophic drugs. Mol Brain Res 2005;136:29–37.
  35. Hong CJ, Yu YW, Lin CH, Tsai SJ: An association study of a brain-derived neurotrophic factor Val66Met polymorphism and clozapine response of schizophrenic patients. Neurosci Lett 2003;349:206–208.

Pay-per-View Options
Direct payment This item at the regular price: USD 38.00
Payment from account With a Karger Pay-per-View account (down payment USD 150) you profit from a special rate for this and other single items.
This item at the discounted price: USD 26.50